Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model

Development of effective vaccines against severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) is still a priority in prevention of re-emergence of SARS. Our previous studies have shown that the receptor-binding domain (RBD) of SARS-CoV spike (S) protein elicits highly potent neutralizing...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Lanying, Zhao, Guangyu, He, Yuxian, Guo, Yan, Zheng, Bo-Jian, Jiang, Shibo, Zhou, Yusen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2007
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115660/
https://www.ncbi.nlm.nih.gov/pubmed/17092615
http://dx.doi.org/10.1016/j.vaccine.2006.10.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115660/
https://www.ncbi.nlm.nih.gov/pubmed/17092615
http://dx.doi.org/10.1016/j.vaccine.2006.10.031

Ejemplares similares